APR is interested to in-license new early stage, innovative and patent protected products/technologies (preferably off patent or close to expiry) for oral, topical or transdermal administration More
Our client is a start up company that is looking for off patent generics indicated for oncology or respiratory disorders and innovative delivery platforms to which to incorporate them into. More